Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Apatinib Combined”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07749859
What this trial is testing

SHR-1701 Plus Apatinib for Second-Line Treatment in Targeted-Immune Pretreated Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Unresectable Hepatocellular Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 80
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06081595
What this trial is testing

Fluzoparib Combined With Apatinib in Relapsed Ovarian Carcinoma Maintenance Treatment

Who this might be right for
Relapsed Ovarian Cancer
Jin Li 54
Testing effectiveness (Phase 2)Looking for participantsNCT06749730
What this trial is testing

Adebrelimab Combined with Apatinib and Gemcitabine and Cisplatin (GP) First-line Treatment for Unresectable Biliary Tract Carcinoma

Who this might be right for
Unresectable Biliary Tract Carcinoma
Henan Cancer Hospital 63
Testing effectiveness (Phase 2)UnknownNCT04101929
What this trial is testing

Apatinib, Irinotecan and S-1 (ApaIRIS) in Treating Patients With Metastatic Pancreatic Cancer After AG Regimen

Who this might be right for
Metastatic Pancreatic Cancer
Fudan University 126
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06694324
What this trial is testing

First-line Treatment of Advanced/unresectable DDLPS

Who this might be right for
Dedifferentiated LiposarcomaSoft Tissue Sarcoma (STS)
Fudan University 49
Testing effectiveness (Phase 2)UnknownNCT04948125
What this trial is testing

Camrelizumab Combined With Apatinib for Advanced Gastric or Esophagogastric Adenocarcinoma

Who this might be right for
Advanced Gastric Carcinoma
Henan Cancer Hospital 20
Testing effectiveness (Phase 2)UnknownNCT03735082
What this trial is testing

Apatinib Combined With Paclitaxel and Carbopatin Intensive Regimen in Neoadjuvant Therapy for Locally Advanced Triple-negative Breast Cancer

Who this might be right for
Breast Cancer
Chinese Academy of Medical Sciences 29
Early research (Phase 1)UnknownNCT03243643
What this trial is testing

Tolerability, Safety, Pharmacokinetics and Efficacy of HS-10241 Single Agent or Combined With Apatinib in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd. 80
Testing effectiveness (Phase 2)UnknownNCT03839550
What this trial is testing

Combine Apatinib Mesylate With PD-1 Antibody SHR-1210 for HCC With High Risk of Recurrence After Radical Resection

Who this might be right for
Hepatocellular Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 200
Not applicableUnknownNCT03531931
What this trial is testing

Apatinib Combined With Capecitabine Second-line Treatment of Advanced Gastric Cancer: a Single-arm Exploratory Clinical Pilot Trial

Who this might be right for
Progression-free Survival;Progression-free Survival;Disease Control Rate; Safety
The First Affiliated Hospital of Xiamen University 20
Testing effectiveness (Phase 2)Looking for participantsNCT05738434
What this trial is testing

Camrelizumab in Combination With Apatinib Mesylate Plus Short-course Chemotherapy for Advanced ESCC

Who this might be right for
Esophageal Cancer by AJCC V8 Stage
The First Affiliated Hospital of Zhengzhou University 188
Testing effectiveness (Phase 2)UnknownNCT03210064
What this trial is testing

Clinical Study of Apatinib and 5-Fu Combination Regimen to Treat Advanced Colorectal Cancer Patients

Who this might be right for
Metastatic Colorectal Cancer
Hui ting Xu，MD 42
Testing effectiveness (Phase 2)Study completedNCT04625803
What this trial is testing

Neoadjuvant Therapy for Locally Advanced Colon Cancer

Who this might be right for
Colon CancerNeoadjuvant Therapy
Zhejiang University 64
Testing effectiveness (Phase 2)UnknownNCT03955354
What this trial is testing

PD-1 Antibody SHR-1210 Combined With Apatinib of First-line Treatment of Advanced Acral Melanoma

Who this might be right for
Melanoma
Peking University Cancer Hospital & Institute 30
Testing effectiveness (Phase 2)UnknownNCT06125171
What this trial is testing

Tucidinostat Plus Apatinib for Advanced Osteosarcoma

Who this might be right for
Osteosarcoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 46
Testing effectiveness (Phase 2)UnknownNCT03154983
What this trial is testing

The Clinical Research of Mesylate Apatinib Combined With Docetaxel and S-1 as the First-line Treatment of Metastatic Gastric Cancer

Who this might be right for
Metastatic Gastric Cancer
Zhou Fuxiang 48
Large-scale testing (Phase 3)UnknownNCT05062837
What this trial is testing

Hepatectomy Combined With Camrelizumab and Apatinib in CNLC Stage IIIb HCC

Who this might be right for
Hepatocellular Carcinoma
Guangxi Medical University 62
Early research (Phase 1)UnknownNCT03491631
What this trial is testing

Phase I Study of SHR9146 + SHR-1210 +/- Apatinib in Patients With Advanced Solid Tumors

Who this might be right for
Tumor, SolidCancer, MetastaticNeoplasm Malignant
Jiangsu HengRui Medicine Co., Ltd. 23
Testing effectiveness (Phase 2)UnknownNCT03086785
What this trial is testing

Prospective, Multicenter, Observational Study of Apatinib Single or Combined Capecitabine for Treatment of Patients With Metastatic Her-2 Negative Breast Cancer

Who this might be right for
Breast Cancer Metastatic
Hebei Medical University Fourth Hospital 120
Large-scale testing (Phase 3)Looking for participantsNCT06255392
What this trial is testing

Randomized, Open, Controlled, Multicenter Phase III Clinical Study of Fluzoparib in Combination With Apatinib Versus Investigator-Selected Chemotherapy for HRD-Positive/HER2-negative Advanced Breast Cancer

Who this might be right for
Fludzoparib" and Anti-angiogenicHRD-positive/HER2-negative Advanced Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 200
Next Page